Summary
Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conducting research in the areas cancers and other immune-mediated diseases. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of disorders and conditions. The company translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. It works in partnership with institutions and biopharmaceutical companies. The company has offices in South San Francisco, San Diego and New York. Adaptive is headquartered in Seattle, Washington, the US.
Adaptive Biotechnologies Corp - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Adaptive Biotechnologies Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Adaptive Biotechnologies Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Sequenta Raises Funds through Venture Financing 10
Sequenta Raises US$20 Million In Series C Financing 11
Sequenta Raises US$8.5 Million In Venture Financing 12
Partnerships 13
Sequenta Enters Into Licensing Agreement With iRepertoire 13
Adaptive Biotech Enters into Partnership with Janssen Biotech 14
Adaptive Biotech Enters into Agreement with Amgen 15
Argos Therapeutics Enters into Research Agreement with Adaptive Biotechnologies 16
Propanc Health Enters into Research Agreement with Adaptive Biotech 17
Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 18
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 19
Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 20
Acquisition 21
Adaptive Biotech Acquires Sequenta 21
Adaptive Biotechnologies Corp - Key Competitors 22
Adaptive Biotechnologies Corp - Key Employees 23
Adaptive Biotechnologies Corp - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting 25
Apr 11, 2016: Adaptive Biotechnologies Welcomes Charles Sang as Senior Vice President of Diagnostics 26
Mar 17, 2016: Seattle’s Adaptive Bio to Base New Drug-Hunting Team in San Diego 27
Mar 15, 2016: Innovation Leader, Diego Miralles, M.D., Joins Adaptive Biotechnologies as President of Adaptive Therapeutics 28
Product News 29
Jun 10, 2016: Adaptive Biotechnologies and Collaborators to Present Data Demonstrating High-Throughput Sequencing for Minimal Residual Disease is More Sensitive Than Flow Cytometry 29
May 14, 2016: Adaptive Biotechnologies to Present 2 Studies Demonstrating Utility of Immunosequencing to Propel Diagnostic Development and Therapeutic Discovery at the 2016 American Association of Immunologists Annual Meeting 30
Apr 16, 2016: Adaptive Biotechnologies and Collaborators to Present 10 Studies Demonstrating the Utility of Immunosequencing in Both Tissue and Blood Samples 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List Of Tables
List of Tables
Adaptive Biotechnologies Corp, Medical Equipment, Key Facts 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Adaptive Biotechnologies Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Adaptive Biotechnologies Corp, Deals By Market, 2011 to YTD 2017 8
Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Sequenta Raises Funds through Venture Financing 10
Sequenta Raises US$20 Million In Series C Financing 11
Sequenta Raises US$8.5 Million In Venture Financing 12
Sequenta Enters Into Licensing Agreement With iRepertoire 13
Adaptive Biotech Enters into Partnership with Janssen Biotech 14
Adaptive Biotech Enters into Agreement with Amgen 15
Argos Therapeutics Enters into Research Agreement with Adaptive Biotechnologies 16
Propanc Health Enters into Research Agreement with Adaptive Biotech 17
Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 18
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 19
Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 20
Adaptive Biotech Acquires Sequenta 21
Adaptive Biotechnologies Corp, Key Competitors 22
Adaptive Biotechnologies Corp, Key Employees 23
Adaptive Biotechnologies Corp, Subsidiaries 24
List Of Figures
List of Figures
Adaptive Biotechnologies Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Adaptive Biotechnologies Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Adaptive Biotechnologies Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
